ACIP Meeting Report – Jan 5th 2022

Following the FDA update on the Emergency Use Authorization (EUA) Fact Sheet for Pfizer-BioNTech COVID-19 vaccine on January 3rd 2022, Advisory Committee on Immunization Practices (ACIP) met to review safety data on this vaccine in children
and adolescents for the purpose of voting on a recommendation to extend use of the booster dose to 12-15yo adolescents.

To view the CDC ACIP Meeting Report from January 5th 2022, see below.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

More Posts